SCHEMBL32665356

SCHEMBL32665356

O=C1C=CC(=O)N1[C@@H]1CCN(c2ccc(OS(=O)(=O)F)cc2)C1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
CCNC P24863 1/20 0.33
CDK8 P49336 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
NOTUM Q6P988 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
L3MBTL3 Q96JM7 1/20 0.33
ALDH1A1 P00352 4/20 0.31
TDP1 Q9NUW8 2/20 0.31
KDM4E B2RXH2 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31
LMNA P02545 2/20 0.31
HSP90AA1 P07900 2/20 0.31
CCR6 P51684 2/20 0.31
CACNA1B Q00975 1/20 0.31
APBA1 Q02410 1/20 0.31
APOBEC3G Q9HC16 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665143 0.92 L3MBTL3 (0.37) L3MBTL1L3MBTL3ALDH1A1TDP1GAA
SCHEMBL32665103 0.89 ALDH1A1 (0.33) ALDH1A1TDP1GAALMNAHSP90AA1
SCHEMBL32665174 0.86 NOTUM (0.40) NOTUML3MBTL1L3MBTL3ALDH1A1
SCHEMBL32665450 0.86 NOTUM (0.40) NOTUML3MBTL1L3MBTL3ALDH1A1
SCHEMBL32665268 0.79 CYP2C9 (0.33) HRH3ALDH1A1TDP1LMNAHSP90AA1
SCHEMBL32665285 0.79 ALDH1A1 (0.36) NOTUML3MBTL1L3MBTL3ALDH1A1MAPT
SCHEMBL32665425 0.76 TDP1 (0.44) HRH3NOTUML3MBTL1L3MBTL3ALDH1A1
SCHEMBL32665396 0.76 HRH1 (0.35) HRH3L3MBTL1ALDH1A1TDP1KDM4E
SCHEMBL32665632 0.74 CHRM4 (0.36) DRD2L3MBTL1ALDH1A1TDP1KDM4E
SCHEMBL17318128 0.64 CA2 (0.52) CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A DRD2 4539/4885DRD4 4678/4885CCNC 2385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.